SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Research from Mirvie has uncovered the biology of preeclampsia, providing unprecedented clarity on pregnancies with the highest risk of the condition.
Home › Businesswire Feed › Mirvie Announces Results from Largest Molecular Study in Pregnancy and Clinical Validation of Simple Blood Test to Predict Risk for Preeclampsia Months Before Symptoms